Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2023 Jan 13;15(2):430.
doi: 10.3390/nu15020430.

Association between Sugar-Sweetened Beverage Consumption and the Risk of the Metabolic Syndrome: A Systematic Review and Meta-Analysis

Ainara Muñoz-Cabrejas  1 , Pilar Guallar-Castillón  2 , Martín Laclaustra  1   3   4 , Helena Sandoval-Insausti  2   5 , Belén Moreno-Franco  1   4   6
Affiliations
Meta-Analysis

Association between Sugar-Sweetened Beverage Consumption and the Risk of the Metabolic Syndrome: A Systematic Review and Meta-Analysis

Ainara Muñoz-Cabrejas et al. Nutrients. .

Abstract

(1) Background: The increasing occurrence of the metabolic syndrome (MetS) is largely related to harmful food habits. Among them, the consumption of sugar-sweetened beverages (SSBs) is noteworthy. However, to our knowledge, there are not enough high-quality methodological studies summarizing the association between the intake of SSBs and the MetS. Therefore, the aim of this study is to examine the existing published results on this association among adults by synthesizing the existing evidence. (2) Methods: Systematic review and meta-analysis of observational studies following the PRISMA guidelines. Relevant information was extracted and presented following the PRISMA recommendations. PubMed and SCOPUS databases were searched for studies published until June 2022 that assessed the association between SSB consumption (including soft drinks, bottled fruit juices, energy drinks, and milkshakes) and the occurrence of MetS. Random effect models were used to estimate pooled odds ratios (ORs) with their 95% coefficient interval, and I2 was used to assess heterogeneity. (3) Results: A total of 14 publications from 6 different countries were included in this meta-analysis (9 cross-sectional and 5 cohort studies). For the cross-sectional studies, which included 62,693 adults, the pooled OR for the risk of MetS was 1.35 (95% CI 1.15, 1.58; I2 57%) when the highest versus the lowest categories of SSB consumption were compared. For the cohort studies, which included 28,932 adults, the pooled OR was 1.18 (95% CI 1.06, 1.32; I2 70%). (4) Conclusions: The consumption of SSBs was positively associated with an increased risk of MetS. The published literature supports public health strategies and the need to reduce the consumption of SSBs to prevent MetS.

Keywords: cardiovascular disease; meta-analysis; metabolic syndrome; sugar-sweetened beverages; systematic review.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
PRISMA 2020 flow diagram for systematic reviews.
Figure 2
Figure 2
Cross-sectional studies forest plot.
Figure 3
Figure 3
Cohort studies forest plot.
See this image and copyright information in PMC

References

    1. Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A., Gordon D.J., Krauss R.M., Savage P.J., Smith S.C., et al. Diagnosis and Management of the Metabolic Syndrome. Circulation. 2005;112:2735–2752. doi: 10.1161/CIRCULATIONAHA.105.169404. - DOI - PubMed
    1. National Cholesterol Education Program (US) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circulation. 2002;106:3143. doi: 10.1161/circ.106.25.3143. - DOI - PubMed
    1. Alberti K.G.M.M., Eckel R.H., Grundy S.M., Zimmet P.Z., Cleeman J.I., Donato K.A., Fruchart J.-C., James W.P.T., Loria C.M., Smith S.C. Harmonizing the Metabolic Syndrome. Circulation. 2009;120:1640–1645. doi: 10.1161/CIRCULATIONAHA.109.192644. - DOI - PubMed
    1. Cuesta M., Fuentes M., Rubio M., Bordiu E., Barabash A., Garcia De La Torre N., Rojo-Martinez G., Valdes S., Soriguer F., Vendrell J.J., et al. Incidence and Regression of Metabolic Syndrome in a Representative Sample of the Spanish Population: Results of the Cohort Di@ Bet. Es Study. BMJ Open Diab. Res. Care. 2020;8:23. doi: 10.1136/bmjdrc-2020-001715. - DOI - PMC - PubMed
    1. Scuteri A., Laurent S., Cucca F., Cockcroft J., Cunha P.G., Mañas L.R., Raso F.U.M., Muiesan M.L., Ryliškyte L., Rietzschel E., et al. The metabolic syndrome across europe—Different clusters of risk factors. Eur. J. Prev. Cardiol. 2015;22:486. doi: 10.1177/2047487314525529. - DOI - PMC - PubMed